Insulet (PODD) shares jump after raising full-year revenue growth guidance

Go back to Insulet (PODD) shares jump after raising full-year revenue growth guidance

Insulet Corporation (PODD) PT Lowered to $264 at TD Cowen

November 3, 2023 8:08 AM EDT

TD Cowen analyst Joshua Jennings lowered the price target on Insulet Corporation (NASDAQ: PODD) to $264.00 (from $300.00) while maintaining a Outperform rating.... More

Insulet Corporation (PODD) PT Lowered to $180 at Baird

November 3, 2023 7:09 AM EDT

Baird analyst Jeff Johnson lowered the price target on Insulet Corporation (NASDAQ: PODD) to $180.00 (from $219.00) while maintaining a Neutral rating.... More

Insulet Corporation (PODD) PT Lowered to $175 at Canaccord Genuity

November 3, 2023 6:49 AM EDT

Canaccord Genuity analyst Kyle Rose lowered the price target on Insulet Corporation (NASDAQ: PODD) to $175.00 (from $355.00) while maintaining a Buy rating.... More

Insulet Corporation (PODD) PT Lowered to $250 at Piper Sandler

November 3, 2023 6:20 AM EDT

Piper Sandler analyst JP McKim lowered the price target on Insulet Corporation (NASDAQ: PODD) to $250.00 (from $325.00) while maintaining a Overweight rating.... More

Insulet (PODD) Tops Q3 EPS by 34c; offers guidance

November 2, 2023 4:05 PM EDT

Insulet (NASDAQ: PODD) reported Q3 EPS of $0.74, $0.34 better than the analyst estimate of $0.40. Revenue for the quarter came in at $432.7 million versus the consensus estimate of $414.32 million.

For the year ending December 31, 2023, the Company is raising its expected revenue growth to a range of 26% to... More